Use of pulsed-field gel electrophoresis in infection control issues concerning Burkholderia cepacia

Infection Control and Hospital Epidemiology

Volumn 24, Issue 8, 2003, Pages 624-626

  Jenney, Adam ^a   Liolios, Lisa ^a   Spelman, Denis ^a   Russo, Philip ^a   Wilson, John ^a   Wesselingh, Steven ^a,b   Kotsimbos, Tom ^a  

^a ALFRED HOSPITAL   (Australia)

^b BURNET INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; CASE REPORT; CULTURE MEDIUM; CYSTIC FIBROSIS; DISEASE TRANSMISSION; HUMAN; INFECTION CONTROL; NONHUMAN; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; RESPIRATORY TRACT INFECTION; STRAIN DIFFERENCE;

BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CROSS INFECTION; CYSTIC FIBROSIS; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; INFECTION CONTROL; PATIENT ISOLATION; PHENOTYPE; SPUTUM; VICTORIA;

EID: 0042932362     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502265     Document Type: Article

References (10)

1. Isles A, Macluskey M, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984;104:206-210.
2. Snell GI, de Hoyos A, Krajden M, et al. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 1993;103:466-471.
3. Paul ML, Pegler MAM, Benn RAV. Molecular epidemiology of Burkholderia cepacia in two Australian cystic fibrosis centres. J Hosp Infect 1998;38:19-26.
4. Govan JRW. Infection control in cystic fibrosis. J R Soc Med 2000;93(suppl 38):40-45.
5. Cystic Fibrosis Australia. Infection Control and Hygiene Guidelines. Sydney: Cystic Fibrosis Australia; 2000.
6. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA-restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
7. Steinbach S, Sun L, Jiang R-Z, et al. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung transplant recipients with cystic fibrosis. N Engl J Med 1994;331:981-987.
8. Pitt TL, Kaufmann ME, Patel PS. The characteristics and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol 1996;44:204-210.
9. Holmes A, Nolan R, Taylor R, et al. An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis 1999;179:1197-1205.
10. Segonds C, Bingen E, Couetdic G, et al. Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centres. J Clin Microbiol 1997;35:2055-2060.